Related Experiment Video
Updated: Sep 18, 2025

Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury
Published on: October 18, 2024
Blood-Brain Barrier Disruption Predicts Poor Outcome in Subarachnoid Hemorrhage: A Dynamic Contrast-Enhanced MRI
Laura Llull1,2, Daniel Santana3,4, Alejandra Mosteiro5
1Neurology Department (L.L., A.C., S.A.), Hospital Clínic, Barcelona, Spain.
Background:
Spontaneous aneurysmal subarachnoid hemorrhage induces early blood-brain barrier permeability dysfunction, although its clinical relevance and underlying mechanisms remain poorly understood. We aimed to evaluate the association between blood-brain barrier disruption, quantified with dynamic contrast-enhanced magnetic resonance imaging at the end of the early brain injury period, circulating neuroinflammatory mediators, and long-term clinical outcomes.
Methods:
We analyzed a prospective cohort of subarachnoid hemorrhage patients who underwent dynamic contrast-enhanced magnetic resonance imaging at a median (interquartile range) of 4 (2-6) days after clinical onset. Permeability maps were used to obtain K-trans values as a measure of increased blood-brain barrier permeability in the whole brain, gray matter, and white matter. Circulating neuroinflammatory molecules, including IL (interleukin) 8 and PDGF (platelet-derived growth factor), were measured using Multiplex-ELISA in blood samples collected concurrently with magnetic resonance imaging acquisition. Poor clinical outcome was defined as a modified Rankin Scale score of >2 at 90 days. Associations between K-trans values, neuroinflammatory mediators, and clinical outcomes were assessed using univariate and multivariate regression models.
Results:
From 153 patients initially screened, 96 were finally included (63% females; median age, 55 years; 43% premorbid hypertension; 32% World Federation of Neurosurgical Societies grade 4-5; 31% poor outcome). In adjusted linear regression analyses, higher K-trans values were significantly associated with increased IL-8 (P=0.001) and PDGF (P=0.018) levels. In univariate analysis, K-trans values in white matter were significantly higher in patients with poor clinical outcome (median [interquartile range], 2.5 [2.07-6.09] ×10-3·min-1) compared with good clinical outcome (median [interquartile range], 2.0 [1.60-2.42] ×10-3·min-1; P<0.001). In models adjusted by age, World Federation of Neurosurgical Societies, hypertension, intraparenchymal hematoma, aneurysm size, and time to magnetic resonance imaging, elevated K-trans values remained independently associated with poor outcome (adjusted odds ratio per interquartile range increase, 3.31 [95% CI, 1.485-7.377]; P=0.003).
Conclusions:
Increased blood-brain barrier permeability correlates with circulating neuroinflammatory mediator levels and is associated with poor clinical recovery at 3 months. These findings support the potential role of white matter permeability alterations as both biomarker and therapeutic target in subarachnoid hemorrhage.
Insights
Blood-brain barrier disruption after subarachnoid hemorrhage correlates with higher levels of inflammatory mediators. Increased white matter permeability is linked to poor clinical outcomes at 90 days.
Area of Science:
- Neurology
- Radiology
- Neuroinflammation
Background:
- Spontaneous aneurysmal subarachnoid hemorrhage (aSAH) causes early blood-brain barrier (BBB) dysfunction.
- The clinical significance and mechanisms of this BBB dysfunction are not well understood.
Purpose of the Study:
- To assess the link between BBB disruption, neuroinflammatory markers, and long-term clinical outcomes after aSAH.
- To evaluate BBB permeability using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).
Main Methods:
- Prospective cohort study of aSAH patients.
- DCE-MRI was used to quantify K-trans values, measuring BBB permeability.
- Circulating levels of IL-8 and PDGF were measured.
- Clinical outcomes were assessed using the modified Rankin Scale at 90 days.
Main Results:
- Higher K-trans values correlated significantly with increased IL-8 and PDGF levels.
- Elevated white matter K-trans values were associated with poor clinical outcomes (modified Rankin Scale >2).
- Adjusted analyses confirmed that elevated K-trans values were an independent predictor of poor outcome.
Conclusions:
- Increased BBB permeability in aSAH patients is associated with higher levels of circulating neuroinflammatory mediators.
- White matter permeability alterations may serve as a biomarker and therapeutic target for improving clinical recovery after aSAH.

